Your browser doesn't support javascript.
loading
Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.
Cani, Andi K; Dolce, Emily M; Darga, Elizabeth P; Hu, Kevin; Liu, Chia-Jen; Pierce, Jackie; Bradbury, Kieran; Kilgour, Elaine; Aung, Kimberly; Schiavon, Gaia; Carroll, Danielle; Carr, T Hedley; Klinowska, Teresa; Lindemann, Justin; Marshall, Gayle; Rowlands, Vicky; Harrington, Elizabeth A; Barrett, J Carl; Sathiyayogan, Nitharsan; Morrow, Christopher; Sero, Valeria; Armstrong, Anne C; Baird, Richard; Hamilton, Erika; Im, Seock-Ah; Jhaveri, Komal; Patel, Manish R; Dive, Caroline; Tomlins, Scott A; Udager, Aaron M; Hayes, Daniel F; Paoletti, Costanza.
Afiliación
  • Cani AK; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Dolce EM; Rogel Cancer Center, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Darga EP; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Hu K; Rogel Cancer Center, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Liu CJ; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Pierce J; Rogel Cancer Center, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Bradbury K; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Kilgour E; Michigan Center for Translational Pathology, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Aung K; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
  • Schiavon G; Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Carroll D; Michigan Center for Translational Pathology, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Carr TH; Cancer Research UK, Manchester Institute Cancer Biomarker Centre, University of Manchester, UK.
  • Klinowska T; Cancer Research UK, Manchester Institute Cancer Biomarker Centre, University of Manchester, UK.
  • Lindemann J; Cancer Research UK, Manchester Institute Cancer Biomarker Centre, University of Manchester, UK.
  • Marshall G; Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Rowlands V; Rogel Cancer Center, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Harrington EA; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Barrett JC; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Sathiyayogan N; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Morrow C; Late Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Sero V; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Armstrong AC; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Baird R; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Hamilton E; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Im SA; Research and Early Development, Oncology R&D, AstraZeneca, Waltham, MA, USA.
  • Jhaveri K; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Patel MR; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Dive C; Menarini Silicon Biosystems, Inc., San Diego, CA, USA.
  • Tomlins SA; Department of Medical Oncology, The Christie NHS Foundation Trust and the Faculty of Biology, Medicine and Health, The University of Manchester, UK.
  • Udager AM; Breast Cancer and Early Phase Clinical Trials Teams, Cancer Research UK, Cambridge Centre, UK.
  • Hayes DF; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN, USA.
  • Paoletti C; Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Mol Oncol ; 16(10): 1969-1985, 2022 05.
Article en En | MEDLINE | ID: mdl-34866317
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / ADN Tumoral Circulante / Células Neoplásicas Circulantes Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / ADN Tumoral Circulante / Células Neoplásicas Circulantes Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos